VERONA PHARMA PLC (VRNA)
Institutional ownership reported to the SEC as of Q4 2025, across 29 quarters.
1
Reporting holders
$359
Reported value
0.0%
Held as options
-224
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | $359 | 20,000 | 0.00% | 13q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 1 | $359 | 20,000 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 225 | $8.2B | 75,831,467 | 84 | 44 | 72 | 1.7% |
| Q2 2025 | 273 | $7.2B | 72,078,911 | 61 | 79 | 97 | 5.7% |
| Q1 2025 | 242 | $4.5B | 67,372,915 | 76 | 65 | 77 | 4.6% |
| Q4 2024 | 185 | $3.1B | 64,380,464 | 47 | 50 | 58 | 2.8% |
| Q3 2024 | 139 | $1.9B | 64,132,504 | 36 | 37 | 43 | 2.6% |
| Q2 2024 | 121 | $958.5M | 64,976,031 | 27 | 41 | 32 | 2.0% |
| Q1 2024 | 109 | $1.1B | 67,458,022 | 13 | 43 | 27 | 0.2% |
| Q4 2023 | 113 | $1.4B | 67,848,597 | 18 | 35 | 28 | 0.4% |
| Q3 2023 | 97 | $1.1B | 64,916,745 | 9 | 34 | 30 | 0.4% |
| Q2 2023 | 97 | $1.3B | 62,429,134 | 16 | 27 | 31 | 0.9% |
| Q1 2023 | 90 | $1.3B | 64,206,789 | 20 | 35 | 17 | 0.4% |
| Q4 2022 | 83 | $1.3B | 49,445,886 | 29 | 21 | 24 | 2.5% |
| Q3 2022 | 69 | $539.3M | 52,074,348 | 42 | 13 | 7 | 1.4% |
| Q2 2022 | 38 | $146.3M | 35,099,135 | 6 | 5 | 5 | 0.3% |
| Q1 2022 | 40 | $181.8M | 36,443,868 | 5 | 8 | 6 | 0.0% |
| Q4 2021 | 42 | $268.1M | 39,834,486 | 9 | 7 | 7 | 0.2% |
| Q3 2021 | 39 | $202.8M | 37,018,796 | 8 | 7 | 5 | 0.0% |
| Q2 2021 | 36 | $258.9M | 39,588,775 | 6 | 6 | 5 | 0.0% |
| Q1 2021 | 38 | $305.2M | 36,531,198 | 8 | 6 | 10 | 0.0% |
| Q4 2020 | 36 | $246.3M | 35,748,292 | 11 | 7 | 4 | 0.1% |
| Q3 2020 | 28 | $212.6M | 34,077,017 | 15 | 8 | 3 | 0.0% |
| Q2 2020 | 18 | $33.6M | 7,173,525 | 5 | 2 | 0 | 0.0% |
| Q1 2020 | 14 | $28.8M | 6,984,029 | 3 | 1 | 4 | 0.0% |
| Q4 2019 | 14 | $33.7M | 5,850,121 | 2 | 3 | 0 | 0.0% |
| Q3 2019 | 13 | $26.8M | 5,862,453 | 0 | 2 | 2 | 0.0% |
| Q2 2019 | 17 | $37.6M | 7,368,489 | 1 | 0 | 4 | 0.0% |
| Q1 2019 | 17 | $47.5M | 7,381,315 | 3 | 2 | 1 | 0.0% |
| Q4 2018 | 17 | $78.6M | 8,407,168 | 1 | 0 | 1 | 0.0% |